Harrow Inc risk profile
31 Normal where most of the sector sits
Measured 1 September 2026 from HROW's filed statements. Recomputed nightly.
31 (Normal), driven by Market expectation at 65, over 5 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 65 | Stretched | Volatile | One-year price volatility — 65.6% |
| Operating pressure | 14 | Contained | Easing | Operating-margin drift — +9.0 percentage points |
| Cash conversion | 11 | Contained | Easing | Capital spending against operating cash — 0.02x |
| Leverage and coverage | 62 | Stretched | Easing | Net debt to EBITDA — 5.56x |
| Competitive position | 29 | Normal | Stable | R&D-intensity gap against peers — -20.2 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.